Effect of pioglitazone on vasopressor responses to adrenergic agonists and angiotensin II in diabetic and non-diabetic spontaneously hypertensive rats

ABSTRACT

Pioglitazone, peroxisome proliferator-activated receptor [PPAR-gamma] agonist, is a therapeutic drug for diabetes. Present study investigated the interaction between PPAR-gamma and alpha adrenoceptors in modulating vasopressor responses to Angiotensin II [Ang II] and adrenergic agonists, in diabetic and non-diabetic Spontaneously Hypertensive Rats [SHRs]. Diabetes was induced with an i.p injection of streptozotocin [40 mg/kg] in two groups [STZ-CON, STZ-PIO], whereas two groups remained non diabetic [ND-CO, ND-PIO]. One diabetic and non-diabetic group received Pioglitazone [10mg/kg] orally for 21 days. On day 28, the animals were anaesthetized with sodium pentobarbitone [60mg/kg] and prepared for measurement of systemic haemodynamics. Basal mean arterial pressure of STZ-CON was higher than NDCON, whereas following pioglitazone treatment, MAP was lower compared to respective controls. MAP responses to i.v administration of NA, PE, ME and ANG II were significantly lower in diabetic SHRs STZ-CON vs. ND-CON [35%]. Pioglitazone significantly decreased responses to NA, PE, ME and ANG II in ND-PIO versus ND-CON by 63%. Responses to NA and ANG II were significantly attenuated in STZ-PIO vs. ND-PIO [40%]. PPAR-gamma regulates systemic hemodynamic in diabetic model and cross-talk relationship exists between PPAR-gamma and alpha1-adrenoceptors, ANG II in systemic vasculature of SHRs